Vaccine and Infectious Disease Division
Biomarkers
Early detection of certain diseases, such as cervical cancer or HIV, is a fundamental strategy for decreasing disease risk. VIDD researchers have shown that identification of clinically relevant biomarkers for detection in combination with early treatment can significantly improve patient survival rates. Biomarkers can also be used to optimize treatment strategies, ensuring each patient is given the treatment most likely to be effective and that unnecessary and ineffective treatment is avoided. Wide-ranging faculty research interests include statistical analyses of clinical trials; identification and evaluation of biomarkers for disease diagnosis, risk, and treatment efficacy; and genetic analysis of disease associations or effects.
- Diseases
& Research
- Treatment
& Support
- About Us
- Labs &
Projects
- Events &
Community Programs
- How You
Can Help Us
The Hutchinson Center's world-renowned scientists are discovering new ways to detect, prevent and treat cancer, HIV/AIDS and many other diseases.
- License Our Discoveries
The Hutchinson Center's world-renowned researchers work together to pursue lifesaving therapies that will help eliminate cancer and related diseases.
The Hutchinson Center's clinical research breakthroughs are delivered to patients through our treatment arm, the Seattle Cancer Care Alliance. This collaboration combines the strengths of the Hutchinson Center, UW Medicine and Seattle Children's.
You can help eliminate cancer and related diseases by attending Hutchinson Center events and participating in our other fundraising and community efforts.
- Divisions
The Hutchinson Center's pioneering researchers push the boundaries of science to find new ways to prevent, detect and treat cancer and related diseases.
Private support is critical to fund new research ideas and innovations, accelerating our ability to make lifesaving discoveries.
